Search research articles
Contact Us
Filters
Showing results (71-80 of 109) with videos related to
Page
of 11
Sort By:
Blood
|
September 9, 1999
Human immunodeficiency virus-1 (HIV-1)-Tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cells
R G Chirivi, G Taraboletti, M R Bani, et al.
International Journal of Cancer
|
August 1, 1994
Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor
R G Chirivi, A Garofalo, M J Crimmin, et al.
Cancer Research
|
December 1, 1991
Malignant behavior and resistance to cisplatin of human ovarian carcinoma xenografts established from the same patient at different stages of the disease
G Masazza, V Lucchini, A Tomasoni, et al.
In Vitro Cellular & Developmental Biology. Animal
|
August 11, 2000
Characterization of novel clonal murine endothelial cell lines with an extended life span
U Cavallaro, V Castelli, A Perilli, et al.
British Journal of Cancer
|
June 21, 2012
Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models
P Oliva, A Decio, V Castiglioni, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1987
Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent
L S Capolongo, G Balconi, P Ubezio, et al.
British Journal of Cancer
|
September 13, 2007
Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel
M Martinelli, K Bonezzi, E Riccardi, et al.
Leukemia Research
|
January 28, 1998
A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice
A Gobbi, C Di Berardino, E Scanziani, et al.
Blood
|
February 7, 2001
Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid
I Ponzanelli, M Giannì, R Giavazzi, et al.
Thrombosis Research
|
May 11, 2016
PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1
D Pinessi, C Foglieni, A Bugatti, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 109) with videos related to
Sort By:
Page
of 11
Blood
|
September 9, 1999
Human immunodeficiency virus-1 (HIV-1)-Tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cells
R G Chirivi, G Taraboletti, M R Bani, et al.
International Journal of Cancer
|
August 1, 1994
Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor
R G Chirivi, A Garofalo, M J Crimmin, et al.
Cancer Research
|
December 1, 1991
Malignant behavior and resistance to cisplatin of human ovarian carcinoma xenografts established from the same patient at different stages of the disease
G Masazza, V Lucchini, A Tomasoni, et al.
In Vitro Cellular & Developmental Biology. Animal
|
August 11, 2000
Characterization of novel clonal murine endothelial cell lines with an extended life span
U Cavallaro, V Castelli, A Perilli, et al.
British Journal of Cancer
|
June 21, 2012
Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models
P Oliva, A Decio, V Castiglioni, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1987
Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent
L S Capolongo, G Balconi, P Ubezio, et al.
British Journal of Cancer
|
September 13, 2007
Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel
M Martinelli, K Bonezzi, E Riccardi, et al.
Leukemia Research
|
January 28, 1998
A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice
A Gobbi, C Di Berardino, E Scanziani, et al.
Blood
|
February 7, 2001
Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid
I Ponzanelli, M Giannì, R Giavazzi, et al.
Thrombosis Research
|
May 11, 2016
PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1
D Pinessi, C Foglieni, A Bugatti, et al.
Page
of 11